Ireland's pharmaceutical market is supplied by a diverse array of sources, including domestic manufacturers, other European Union (EU) countries, China, and emerging markets. The EU, with its robust pharmaceutical industry, is a significant supplier to Ireland, benefiting from proximity and shared regulatory standards. China has also been increasing its presence in the global pharmaceutical supply chain, offering competitive pricing and a growing range of products. Emerging markets, such as those in Latin America and Southeast Asia, are gradually entering the Irish market, attracted by the potential for growth and the demand for cost-effective solutions. However, specific market share data for these regions is not readily available.
India's pharmaceutical exports to Ireland amounted to $26.5 million USD over 1,490 shipments from 2022 to 2026, with an average shipment value of $18,000. This positions India as a notable supplier, though precise market share figures are not specified. The top Indian exporters to Ireland include IND SWIFT LIMITED, DR.REDDY'S LABORATORIES LTD, GRANULES INDIA LIMITED, AURIGENE PHARMACEUTICAL SERVICES LIMITED, and UNICHEM LABORATORIES LIMITED. The leading Irish buyers are CHANELLE MEDICAL, ALMAC CLINICAL SERVICES LTD, and GLAXOSMITHKLINE DUNGARVAN LTD.
